The Valley Desk

ArticleJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2

18 of 33 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Quinolines; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Protein Kinase Inhibitors; Mutation; Adult; Aged; Aged, 80 and over; Middle Aged
PubMed ID
41325571
PubMed Central ID
PMC12736406
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal